PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Chiara Tommasi

University of Parma

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · JOURNAL ARTICLE

Isocitrate dehydrogenase (IDH) as target for anticancer therapy in brain and gastrointestinal cancers

Discover Medicine

A narrative review synthesizing evidence on IDH inhibitors across multiple cancer types, discussing FDA-approved agents, clinical trial data, and resistance mechanisms—informative for clinical decision-making but not reporting original empirical results.

Expert GuidanceEleonora Lai Cholangiocarcinoma and Gallbladder Cancer Studies Virginia Agnetti

Study details

DesignNarrative review

InterventionIDH inhibitors (ivosidenib, vorasibenib, an…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support